![](\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2015\/11\/metabolik-cerrahi-seker-hastaliginiza-care-olabilir_db276f6.jpg\")
Laparaskopik Bariatrik ve Metabolik Cerrah Op.Dr.Muzaffer Al, \u201cMetabolik cerrahi \u015feker hastal\u0131\u011f\u0131n\u0131za \u00e7are olabilir\u201d dedi.<\/p>\nLaparaskopik Bariatrik ve Metabolik Cerrah Op.Dr.Muzaffer Al, \u201cMetabolik cerrahi \u015feker hastal\u0131\u011f\u0131n\u0131za \u00e7are olabilir\u201d dedi.<\/p>\n
Diyabet\u2019in ins\u00fclin eksikli\u011fi, ins\u00fclin direnci veya her ikisinin birlikteli\u011fi sonucu kanda glukoz seviyesinin y\u00fckselmesine ba\u011fl\u0131 olarak geli\u015fen sistemik bir hastal\u0131k oldu\u011funu anlatan Op.Dr.Muzaffer Al, \u201cG\u00fcn\u00fcm\u00fczde diyabet, s\u0131kl\u0131\u011f\u0131 ve yaratt\u0131\u011f\u0131 sorunlar nedeniyle t\u00fcm d\u00fcnyada \u00f6nemi gittik\u00e7e artan bir sa\u011fl\u0131k sorunu olarak kar\u015f\u0131m\u0131za \u00e7\u0131kmaktad\u0131r. Ya\u015fam tarz\u0131ndaki h\u0131zl\u0131 de\u011fi\u015fim ile birlikte geli\u015fmi\u015f ve geli\u015fmekte olan toplumlar\u0131n t\u00fcm\u00fcnde \u00f6zellikle tip 2 diyabet s\u0131kl\u0131\u011f\u0131 h\u0131zla y\u00fckselmektedir\u201d diye konu\u015ftu.<\/p>\n
2013 y\u0131l\u0131 itibari ile d\u00fcnyadaki diyabetli birey say\u0131s\u0131 382 milyon iken bu say\u0131n\u0131n 2035 y\u0131l\u0131nda y\u00fczde 55 oran\u0131nda artarak 592 milyona ula\u015faca\u011f\u0131n\u0131n \u00f6ng\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc kaydeden Op.Dr.Muzaffer Al, \u201c\u00dclkemiz Avrupa\u2019da 20-79 ya\u015f aras\u0131 en fazla diyabetli bireyin bulundu\u011fu \u00fclkeler s\u0131ralamas\u0131nda 7 milyonu a\u015fk\u0131n ki\u015fiyle Rusya ve Almanya\u2019dan sonra 3. s\u0131rada yer almaktad\u0131r. Bu art\u0131\u015f\u0131n ba\u015fl\u0131ca nedenleri n\u00fcfus art\u0131\u015f\u0131, ya\u015flanma ve kentle\u015fmenin getirdi\u011fi ya\u015fam tarz\u0131 de\u011fi\u015fimi sonucu obezite ve fiziksel aktivitenin azalmas\u0131d\u0131r. Beslenme ve ya\u015fam tarz\u0131ndaki yanl\u0131\u015fl\u0131klara ba\u011fl\u0131 olarak son y\u0131llarda \u00e7ocuklarda ve gen\u00e7lerde de tip 2 diyabet prevalans\u0131 h\u0131zla artmaktad\u0131r. Diyabet t\u00fcm d\u00fcnyada \u00f6l\u00fcm nedenleri aras\u0131nda 8. s\u0131rada yer almaktad\u0131r. 2013 y\u0131l\u0131nda t\u00fcm d\u00fcnyada 5.1 milyon insan\u0131n diyabet ve komplikasyonlar\u0131 nedeniyle hayat\u0131n\u0131 kaybetti\u011fi rapor edilmi\u015ftir\u201d \u015feklinde konu\u015ftu.<\/p>\n
Kontrols\u00fcz diyabetin kanda kan \u015fekerinde y\u00fckselmeye yol a\u00e7arak zamanla ba\u015fta kalp-damar sistemi, g\u00f6z, b\u00f6brek, sinir sistemi olmak \u00fczere v\u00fccudun b\u00fct\u00fcn sistemlerini etkileyen komplikasyonlar\u0131n geli\u015fmesine neden olabildi\u011fini anlatan Op.Dr.Muzaffer Al, \u201cAyr\u0131ca, diyabetli bireylerde infeksiyon geli\u015fme riski, diyabeti olmayanlara oranla daha y\u00fcksektir. Kalp ve damar hastal\u0131klar\u0131n s\u0131kl\u0131\u011f\u0131 ve \u00f6l\u00fcm riski diyabeti olmayan akranlar\u0131na k\u0131yasla 2-8 kat daha y\u00fcksektir . Diyabetlilerin %60-75\u2019i kardiyovask\u00fcler hastal\u0131klar (koroner arter hastal\u0131\u011f\u0131 ve inme) nedeniyle kaybedilmektedir T\u00fcm d\u00fcnyada b\u00f6brek yetersizli\u011finin ve travma-d\u0131\u015f\u0131 amputasyon (kol ve bacaklar\u0131n k\u0131smen ya da tamamen kesilmesi) olgular\u0131n\u0131n en yayg\u0131n nedeni diyabettir. Diyabetli bireylerde alt ekstremite amputasyon riski diyabeti olmayanlara oranla 25 kat y\u00fcksektir. \u00d6zellikle geli\u015fmi\u015f \u00fclkelerde diyabet en s\u0131k g\u00f6rme kayb\u0131 ve k\u00f6rl\u00fck nedenlerinden biridir. Diyabetik retinopati, diyabet s\u00fcresi 15 y\u0131la ula\u015fan diyabetlilerin y\u00fczde 2\u2019sinde k\u00f6rl\u00fck ve y\u00fczde 10\u2019unda ciddi g\u00f6rme kayb\u0131na neden olur . Diyabet, kronik b\u00f6brek yetersizli\u011finin en s\u0131k g\u00f6r\u00fclme nedenidir. Diyaliz \u00fcnitelerinde tedavi g\u00f6ren hastalar\u0131n y\u00fczde 50\u2019si diyabetlidir. Diyabetli bireylerin y\u00fczde 20-40\u2019\u0131nda diyabetik nefropati geli\u015fir. Diyabetik nefropatili bireylerin y\u00fczde 10-20\u2019si b\u00f6brek yetersizli\u011fi nedeniyle kaybedilir. Diyabetik nefropati geli\u015fen hastalarda kardiyovask\u00fcler hastal\u0131k riski artar. Diyabetin periferik ve otonom sinirlerde de hasar yapar. En s\u0131k g\u00f6r\u00fclen belirtiler ayaklarda uyu\u015fma, yanma, kar\u0131ncalanma, a\u011fr\u0131 ve g\u00fc\u00e7s\u00fczl\u00fckt\u00fcr. Diyabetlilerde periferik n\u00f6ropati, periferik arter hastal\u0131\u011f\u0131 ve infeksiyona yatk\u0131nl\u0131k nedeniyle ayak \u00fclserleri ve nihayetinde amputasyonlar s\u0131k g\u00f6r\u00fcl\u00fcr. En \u00f6nemli neden diyabetik n\u00f6ropatinin yaratt\u0131\u011f\u0131 hissizlik sonucu tekrarlayan travmalar\u0131n fark edilmemesidir. \u00c7al\u0131\u015fmalar, travmatik nedenler d\u0131\u015f\u0131nda, ayak amputasyonuna yol a\u00e7an sebeplerin % 60\u2019\u0131n\u0131n diyabetten kaynakland\u0131\u011f\u0131n\u0131 g\u00f6stermektedir\u201d dedi.<\/p>\n
\u0130nsan sa\u011fl\u0131\u011f\u0131n\u0131 tehdit eden kronik bir hastal\u0131k olmas\u0131 yan\u0131nda, diyabetin hem bireye hem de \u00fclkelerin sa\u011fl\u0131k sistemlerine maliyeti olduk\u00e7a y\u00fcksek oldu\u011funu da dile getiren Op.Dr.Muzaffer Al, daha sonra \u015funlar\u0131 s\u00f6yledi; \u201cDiyabet ve ili\u015fkili hastal\u0131klar\u0131n takip ve tedavi maliyetlerinden kaynaklanan do\u011frudan maliyetler yan\u0131nda, bireyin i\u015f verimlili\u011finin azalmas\u0131, ya\u015fam s\u00fcresinin k\u0131salmas\u0131 ve hasta yak\u0131nlar\u0131n\u0131n me\u015fguliyetlerinden kaynaklanan dolayl\u0131 maliyetlerin de g\u00f6z \u00f6n\u00fcnde bulundurulmas\u0131 gerekir.<\/p>\n
Diyabet tedavisinde hedef kan glukozunun normal d\u00fczeylere indirilmesi ile birlikte mikro ve makrovask\u00fcler komplikasyonlar\u0131n ve kardiyovask\u00fcler risk fakt\u00f6rlerinin kontrol alt\u0131na al\u0131nmas\u0131d\u0131r. Kilo kontrol\u00fc sa\u011flanmas\u0131 ve yan\u0131s\u0131ra kan bas\u0131nc\u0131 ve lipid d\u00fczeyleri gibi di\u011fer bilinen risk fakt\u00f6rlerinin de kontrol edilmesi gereklidir.<\/p>\n
Diyabet (\u015eeker hastal\u0131\u011f\u0131 )tedavisi, klasik olarak beslenme \u015fekline uygun \u015feker hastal\u0131\u011f\u0131 diyeti ve d\u00fczenli egzersiz ile ba\u015flar, \u015feker haplar\u0131 ve ins\u00fclin ile devam eder.Diyabet hastalar\u0131n\u0131n genellikle 10-12 y\u0131l i\u00e7inde ins\u00fclin depolar\u0131n\u0131n tamam\u0131n\u0131 t\u00fcketmektedir.Bundan sonrada s\u00fcrekli is\u00fclin tedavisine ba\u011f\u0131ml\u0131 kalmaktad\u0131r. Bu tedaviler, \u015feker hastal\u0131\u011f\u0131na ba\u011fl\u0131 ortaya \u00e7\u0131kan k\u00f6rl\u00fck, b\u00f6brek yetersizli\u011fi, kalp krizi, inme ve fel\u00e7lerin ortaya \u00e7\u0131k\u0131\u015f\u0131n\u0131 k\u0131smen azaltabilir. Ancak uzun d\u00f6nemde bu sorunlar\u0131 etkin olarak engelleyemez ve \u015feker hastal\u0131\u011f\u0131na kesin \u00e7\u00f6z\u00fcm sa\u011flamaz.<\/p>\n
\u015eeker hastal\u0131\u011f\u0131na ba\u011fl\u0131 olu\u015fabilecek bu sorunlar uzun y\u0131llard\u0131r g\u00fcvenilirli\u011fi ve etkinli\u011fi kan\u0131tlanm\u0131\u015f ameliyat y\u00f6ntemleriyle(Metabolik Cerrahi) tedavi edilebilmektedir. \u00c7al\u0131\u015fmalar Metabolik cerrahinin ins\u00fclin direnci ve sal\u0131n\u0131m\u0131n\u0131 gastrointestinal hormonal de\u011fi\u015fikliklere ba\u011fl\u0131 olarak kilo kayb\u0131ndan ba\u011f\u0131ms\u0131z olarak d\u00fczeltti\u011fini g\u00f6stermi\u015ftir.<\/p>\n
\u0130nce ba\u011f\u0131rsa\u011f\u0131m\u0131z\u0131n ba\u015flang\u0131\u00e7 k\u0131sm\u0131nda ins\u00fclin diren\u00e7 hormonlar\u0131 son k\u0131s\u0131mlar\u0131nda ins\u00fclin duyarl\u0131l\u0131\u011f\u0131n\u0131 art\u0131ran hormonlar salg\u0131lan\u0131r. Metabolik cerrahi(tip 2 \u015feker hastal\u0131\u011f\u0131 ameliyat\u0131) ile ins\u00fclin duyarl\u0131l\u0131\u011f\u0131n\u0131 art\u0131ran hormonlar\u0131 i\u00e7eren inceba\u011f\u0131rsa\u011f\u0131n son k\u0131sm\u0131 daha \u00f6ne al\u0131narak g\u0131dan\u0131n bu ba\u011f\u0131rsak b\u00f6l\u00fcm\u00fcne daha erken girmesini sa\u011flanmakta ve bunun sonucunda pankreas beta h\u00fccrelerinde ins\u00fclin salg\u0131lama kapasitesi artmaktad\u0131r. ins\u00fclin direnci sa\u011flayan ince ba\u011f\u0131rsa\u011f\u0131n ba\u015flang\u0131\u00e7 k\u0131sm\u0131n\u0131n aktivitesi azalt\u0131lmaktad\u0131r. Ayr\u0131ca fonksiyonel doygunluk hissi sa\u011flanarak a\u015f\u0131r\u0131 yemek yeme iste\u011fi azalt\u0131lmaktad\u0131r. Bu da \u015feker hastal\u0131\u011f\u0131 tedavisine olumlu katk\u0131 sa\u011flamaktad\u0131r.Metabolik cerrahi tip 2 \u015feker hastalar\u0131n\u0131n %75 -98\u2019inde rezol\u00fcsyon (tam iyile\u015fme) sa\u011flamaktad\u0131r. 8 ila 10 y\u0131ll\u0131k takiplerde tip 2 \u015feker hastalar\u0131n\u0131n ila\u00e7 ve ins\u00fclinsiz bu iyilik halini s\u00fcrd\u00fcrd\u00fckleri ortaya konmu\u015ftur. Metabolik cerrahi laparaskopik yani milimetrik k\u00fc\u00e7\u00fck kesilerden girilerek uygulanabilmektedir.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
LAPARASKOP\u0130K BAR\u0130ATR\u0130K VE METABOL\u0130K CERRAH OP. DR. MUZAFFER AL, \u201cMETABOL\u0130K CERRAH\u0130 \u015eEKER HASTALI\u011eINIZA \u00c7ARE OLAB\u0130L\u0130R\u201d DED\u0130.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[25439,18036,25438,25437,1214,3611],"class_list":["post-137974","post","type-post","status-publish","format-standard","hentry","category-saglik","category-turkiye","tag-care","tag-cerrahi","tag-hastaliginiza","tag-metabolik","tag-olabilir","tag-seker"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts\/137974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=137974"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=\/wp\/v2\/posts\/137974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=137974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=137974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=137974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}